UC Davis conducting clinical trials of two drugs to treat COVID-19

The studies are evaluating the safety and effectiveness of the investigational antiviral drug remdesivir, and sarilumab, a drug that blocks the body’s acute inflammatory response.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.